TLR agonists (Montana University/Inimmune)

N/A

Report date: 2025/01/26 16:06:42

Base Information

Drug NameTLR agonists (Montana University/Inimmune)
Drug Alias NameTLR agonists (Montana University/Inimmune)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionToll-like receptor agonists
TargetsToll-like receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Montana
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MontanaInimmune Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A